 | Up a level |
Ørnbjerg, Lykke Midtbøll; Rugbjerg, Kathrine; Georgiadis, Stylianos; Rasmussen, Simon Horskjær; Jacobsson, Lennart; Loft, Anne Gitte; Iannone, Florenzo; Fagerli, Karen Minde; Vencovsky, Jiri; Santos, Maria José; Möller, Burkhard; Pombo-Suarez, Manuel; Rotar, Ziga; Gudbjornsson, Bjorn; Cefle, Ayse; Eklund, Kari; Codreanu, Catalin; Jones, Gareth; van der Sande, Marleen; Wallman, Johan Karlsson; ... (2024). Patient-reported outcomes and PRO remission rates in 12,262 biologic-naïve patients with psoriatic arthritis treated with TNF-inhibitors in routine care. The journal of rheumatology, 51(4), pp. 378-389. The Journal of Rheumatology Publishing Company Limited 10.3899/jrheum.2023-0764
Michelsen, Brigitte; Østergaard, Mikkel; Nissen, Michael John; Ciurea, Adrian; Möller, Burkhard; Ørnbjerg, Lykke Midtbøll; Zavada, Jakub; Glintborg, Bente; MacDonald, Alan; Laas, Karin; Nordström, Dan; Gudbjornsson, Bjorn; Iannone, Florenzo; Hellmand, Pasoon; Kvien, Tore Kristian; Rodrigues, Ana Maria; Codreanu, Catalin; Rotar, Ziga; Castrejón Fernández, Isabel; Wallman, Johan Karlsson; ... (2023). Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe. The Lancet regional health. Europe, 33(100706), p. 100706. Elsevier 10.1016/j.lanepe.2023.100706
